A detailed history of Hb Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hb Wealth Management, LLC holds 32,262 shares of AZN stock, worth $2.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
32,262
Previous 30,160 6.97%
Holding current value
$2.15 Million
Previous $2.35 Million 6.85%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$76.67 - $87.62 $161,160 - $184,177
2,102 Added 6.97%
32,262 $2.51 Million
Q2 2024

Jul 26, 2024

BUY
$66.81 - $80.83 $67,611 - $81,799
1,012 Added 3.47%
30,160 $2.35 Million
Q1 2024

Apr 30, 2024

BUY
$61.03 - $69.57 $42,354 - $48,281
694 Added 2.44%
29,148 $1.97 Million
Q4 2023

Jan 16, 2024

BUY
$61.89 - $69.28 $21,909 - $24,525
354 Added 1.26%
28,454 $1.92 Million
Q3 2023

Oct 13, 2023

BUY
$64.85 - $71.7 $241,371 - $266,867
3,722 Added 15.27%
28,100 $1.9 Million
Q2 2023

Jul 13, 2023

BUY
$69.91 - $75.81 $2,307 - $2,501
33 Added 0.14%
24,378 $1.74 Million
Q1 2023

Apr 13, 2023

SELL
$63.15 - $71.6 $5,241 - $5,942
-83 Reduced 0.34%
24,345 $1.69 Million
Q4 2022

Jan 20, 2023

BUY
$54.21 - $70.44 $850,771 - $1.11 Million
15,694 Added 179.69%
24,428 $0
Q3 2022

Oct 19, 2022

BUY
$53.02 - $135.75 $33,190 - $84,979
626 Added 7.72%
8,734 $479,000
Q2 2022

Jul 15, 2022

SELL
$59.26 - $71.14 $44,919 - $53,924
-758 Reduced 8.55%
8,108 $536,000
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $162,869 - $196,191
2,923 Added 49.18%
8,866 $588,000
Q4 2021

Feb 15, 2022

BUY
$54.02 - $63.83 $321,040 - $379,341
5,943 New
5,943 $346,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.